Atea Pharmaceuticals shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by China Universal Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $54k | 16k | 3.35 |
| 2024-06-30 | $33k | 9.9k | 3.31 |
| 2024-03-31 | $65k | 16k | 4.04 |
| 2023-12-31 | $29k | 9.7k | 3.05 |
| 2023-09-30 | $6.4k | 2.1k | 3.00 |
| 2023-06-30 | $4.1k | 1.1k | 3.74 |
| 2023-03-31 | $3.8k | 1.1k | 3.35 |
| 2022-12-31 | $4.1k | 846 | 4.81 |
| 2022-09-30 | $4.0k | 780 | 5.13 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management